入院时鲍曼不动杆菌定植的低流行率。
Low prevalence of Acinetobacter baumannii colonization on hospital admission.
机构信息
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, 100 N. Greene Street, Baltimore, MD 21201, USA.
出版信息
Am J Infect Control. 2010 May;38(4):329-31. doi: 10.1016/j.ajic.2009.10.006. Epub 2010 Mar 2.
Abstract
We conducted a prospective cohort study of non-critically ill patients admitted to a tertiary care center between December 2003 and September 2004 and obtained perirectal samples at hospital admission to determine the prevalence of Acinetobacter baumannii. A baumannii was isolated from 1 of 555 cultures (0.18%); no multidrug-resistant A baumannii was identified. Interventions aimed at early identification of A baumannii-colonized patients may not benefit by widely targeting non-critically ill patients on hospital admission.
摘要
我们对 2003 年 12 月至 2004 年 9 月期间入住一家三级护理中心的非危重病患者进行了一项前瞻性队列研究，并在入院时获得了直肠周围样本，以确定鲍曼不动杆菌的流行率。从 555 个培养物中分离出鲍曼不动杆菌 1 株（0.18%）；未鉴定出耐多药鲍曼不动杆菌。旨在早期识别定植鲍曼不动杆菌患者的干预措施可能不会通过广泛针对入院时非危重病患者而获益。
相似文献
1
Low prevalence of Acinetobacter baumannii colonization on hospital admission.入院时鲍曼不动杆菌定植的低流行率。
Am J Infect Control. 2010 May;38(4):329-31. doi: 10.1016/j.ajic.2009.10.006. Epub 2010 Mar 2.
2
[Prevalence of Acinetobacter baumannii carriage in patients of 53 French intensive care units on a given day].[某一特定日期法国53个重症监护病房患者鲍曼不动杆菌携带情况的患病率]
Med Mal Infect. 2007 Feb;37(2):112-7. doi: 10.1016/j.medmal.2006.12.002. Epub 2007 Jan 26.
3
Intestinal carriage of antibiotic resistant Acinetobacter baumannii among newborns hospitalized in Moroccan neonatal intensive care unit.摩洛哥新生儿重症监护病房住院新生儿中产超广谱β-内酰胺酶鲍曼不动杆菌的肠道定植。
PLoS One. 2019 Jan 10;14(1):e0209425. doi: 10.1371/journal.pone.0209425. eCollection 2019.
4
Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients.评估CHROMagar不动杆菌培养基用于检测重症患者样本中多重耐药鲍曼不动杆菌肠道携带情况的效果。
J Clin Microbiol. 2009 Jul;47(7):2249-51. doi: 10.1128/JCM.00634-09. Epub 2009 May 13.
5
Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission.入住重症监护病房时与多重耐药鲍曼不动杆菌相关的危险因素和结局。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01631-17. Print 2018 Jan.
6
Screening for carbapenem-resistant Acinetobacter baumannii colonization sites: an implication for combination of horizontal and vertical approaches.耐碳青霉烯鲍曼不动杆菌定植部位的筛查：水平与垂直方法联合应用的意义
Clin Infect Dis. 2013 Apr;56(7):1057-9. doi: 10.1093/cid/cis1024. Epub 2012 Dec 7.
7
Prevalence and risk factors for carriage of carbapenem-resistant in post-acute care hospitals, Israel, 2021.2021年以色列急症后护理医院耐碳青霉烯类携带情况及危险因素
Euro Surveill. 2025 Apr;30(15). doi: 10.2807/1560-7917.ES.2025.30.15.2400563.
8
Molecular epidemiology of multidrug-resistant clinical isolates of Acinetobacter baumannii : A 10-year analysis in a large tertiary care university hospital in central Europe with international admissions.多药耐药临床分离鲍曼不动杆菌的分子流行病学：中欧一家大型三级教学医院的 10 年分析，包括国际收治患者。
Wien Klin Wochenschr. 2017 Nov;129(21-22):816-822. doi: 10.1007/s00508-017-1242-7. Epub 2017 Aug 3.
9
Metallo-beta-lactamase expressing multi-resistant Acinetobacter baumannii transmitted in the operation area.产金属β-内酰胺酶的多重耐药鲍曼不动杆菌在手术区域传播。
J Hosp Infect. 2004 Aug;57(4):308-15. doi: 10.1016/j.jhin.2004.04.016.
10
Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital.耐多药鲍曼不动杆菌：城市医院的描述性研究。
BMC Infect Dis. 2010 Jul 7;10:196. doi: 10.1186/1471-2334-10-196.
引用本文的文献
1
Identifying risk factors for carbapenem-resistant Acinetobacter baumannii carriage upon admission: a case-case control study.入院时耐碳青霉烯鲍曼不动杆菌携带的危险因素识别：一项病例-病例对照研究
Antimicrob Resist Infect Control. 2024 Dec 20;13(1):153. doi: 10.1186/s13756-024-01500-7.
2
Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii.使用氟喹诺酮类药物是多重耐药鲍曼不动杆菌在鼻腔和胃肠道定植患者中细菌载量高的唯一最重要风险因素。
Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2359-66. doi: 10.1007/s10096-015-2489-4. Epub 2015 Sep 15.
3
Modeling the impact of interventions against Acinetobacter baumannii transmission in intensive care units.模拟重症监护病房中针对鲍曼不动杆菌传播的干预措施的影响。
Virulence. 2016;7(2):141-52. doi: 10.1080/21505594.2015.1076615. Epub 2015 Aug 7.
4
Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity.对不同人体部位分离的多药耐药侵袭性和定植性鲍曼不动杆菌进行基因组比较，揭示了基因组的可塑性。
BMC Genomics. 2011 Jun 4;12:291. doi: 10.1186/1471-2164-12-291.
本文引用的文献
1
Incidence and prevalence of multidrug-resistant acinetobacter using targeted active surveillance cultures.采用目标性主动监测培养法对多重耐药不动杆菌的发病率和患病率进行研究。
JAMA. 2008 Jun 4;299(21):2513-4. doi: 10.1001/jama.299.21.2513.
2
Impact of freezing on the future utility of archived surveillance culture specimens.冷冻对存档监测培养标本未来效用的影响。
Infect Control Hosp Epidemiol. 2007 Jul;28(7):886-8. doi: 10.1086/518843. Epub 2007 May 31.
3
Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii.多重耐药鲍曼不动杆菌的监测培养及携带持续时间
J Clin Microbiol. 2007 May;45(5):1551-5. doi: 10.1128/JCM.02424-06. Epub 2007 Feb 21.
4
Identifying groups at high risk for carriage of antibiotic-resistant bacteria.识别携带抗生素耐药菌的高危人群。
Arch Intern Med. 2006 Mar 13;166(5):580-5. doi: 10.1001/archinte.166.5.580.
5
Overview of nosocomial infections caused by gram-negative bacilli.革兰氏阴性杆菌引起的医院感染概述。
Clin Infect Dis. 2005 Sep 15;41(6):848-54. doi: 10.1086/432803. Epub 2005 Aug 16.
6
Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.重症监护病房中由耐抗生素革兰氏阴性菌引起的医院获得性菌血症的定植状态及适当的抗生素治疗
Infect Control Hosp Epidemiol. 2005 Jun;26(6):575-9. doi: 10.1086/502575.
7
Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.耐抗生素革兰氏阴性杆菌引起的血流感染：死亡风险因素及初始抗菌治疗不当对结局的影响。
Antimicrob Agents Chemother. 2005 Feb;49(2):760-6. doi: 10.1128/AAC.49.2.760-766.2005.
8
Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial.早期经验性抗生素治疗的充分性与严重脓毒症患者的生存率：来自MONARCS试验的经验
Clin Infect Dis. 2004 Jan 15;38(2):284-8. doi: 10.1086/379825. Epub 2003 Dec 22.
9
Colonization by Acinetobacter baumanii in intensive-care-unit patients.鲍曼不动杆菌在重症监护病房患者中的定植情况。
Infect Control Hosp Epidemiol. 1998 Mar;19(3):188-90. doi: 10.1086/647793.
10
Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients.重症监护病房患者中多重耐药鲍曼不动杆菌在皮肤、咽部和消化道定植的流行病学意义
J Hosp Infect. 1997 Dec;37(4):287-95. doi: 10.1016/s0195-6701(97)90145-6.
Zotero 插件